MedTrace Logo

G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly Patients

NCT00401609 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2016-01-14

No results posted yet for this study

Summary

The purpose of this study is to describe the activity and toxicity of gemcitabine combined with four different drugs (carboplatin or cisplatin or etoposide or vinorelbine) as first line treatment of elderly patients with extensive small cell lung cancer.

Conditions

Interventions

DRUG

gemcitabine

DRUG

vinorelbine

DRUG

cisplatin

DRUG

etoposide

DRUG

carboplatin

Sponsors & Collaborators

  • National Cancer Institute, Naples

    lead OTHER

Principal Investigators

  • Cesare Gridelli, M.D. · San Giuseppe Moscati Hospital, Avellino, Italy

  • Francesco Perrone, M.D., Ph.D. · National Cancer Institute Naples, Italy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-11-30
Primary Completion
2007-12-31
Completion
2009-02-28

Countries

  • Italy

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00401609 on ClinicalTrials.gov